U.S. patent application number 16/592804 was filed with the patent office on 2020-01-30 for mitral valve prosthesis and methods for implantation.
The applicant listed for this patent is Medtronic Ventor Technologies Ltd.. Invention is credited to Eli Ben-Hamou, Ilia Hariton, Igor Kovalsky, Yosi Tuval.
Application Number | 20200030092 16/592804 |
Document ID | / |
Family ID | 44477163 |
Filed Date | 2020-01-30 |
![](/patent/app/20200030092/US20200030092A1-20200130-D00000.png)
![](/patent/app/20200030092/US20200030092A1-20200130-D00001.png)
![](/patent/app/20200030092/US20200030092A1-20200130-D00002.png)
![](/patent/app/20200030092/US20200030092A1-20200130-D00003.png)
![](/patent/app/20200030092/US20200030092A1-20200130-D00004.png)
![](/patent/app/20200030092/US20200030092A1-20200130-D00005.png)
![](/patent/app/20200030092/US20200030092A1-20200130-D00006.png)
![](/patent/app/20200030092/US20200030092A1-20200130-D00007.png)
![](/patent/app/20200030092/US20200030092A1-20200130-D00008.png)
![](/patent/app/20200030092/US20200030092A1-20200130-D00009.png)
![](/patent/app/20200030092/US20200030092A1-20200130-D00010.png)
View All Diagrams
United States Patent
Application |
20200030092 |
Kind Code |
A1 |
Tuval; Yosi ; et
al. |
January 30, 2020 |
Mitral Valve Prosthesis and Methods for Implantation
Abstract
Apparatus and methods are provided including a mitral valve
prosthesis. The prosthesis includes an inner support structure
having downstream and upstream sections, the upstream section
having a cross-sectional area greater than the downstream section.
The inner support structure is configured to be positioned on an
atrial side of the native valve complex, and to prevent the
prosthesis from being dislodged into the left ventricle. A
prosthetic valve having prosthetic valve leaflets is coupled to the
inner support structure. An outer support structure has engagement
arms, downstream ends of the engagement arms being coupled to the
inner support structure. The prosthesis is configured such that,
upon implantation thereof: downstream ends of the native valve
leaflets, downstream ends of the engagement arms, and downstream
ends of the prosthetic leaflets, are disposed at a longitudinal
distance from one another of less than 3 mm. Other embodiments are
also described.
Inventors: |
Tuval; Yosi; (Even Yehuda,
IL) ; Hariton; Ilia; (Zichron Yaackov, IL) ;
Kovalsky; Igor; (Givatamin, IL) ; Ben-Hamou; Eli;
(Tel Aviv, IL) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Medtronic Ventor Technologies Ltd. |
Minneapolis |
MN |
US |
|
|
Family ID: |
44477163 |
Appl. No.: |
16/592804 |
Filed: |
October 4, 2019 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
12914611 |
Oct 28, 2010 |
10433956 |
|
|
16592804 |
|
|
|
|
61307743 |
Feb 24, 2010 |
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61F 2/2418 20130101;
A61F 2230/008 20130101; A61F 2230/005 20130101; A61F 2230/0013
20130101; A61F 2/2412 20130101; A61F 2220/0008 20130101; A61F
2/2436 20130101; A61F 2220/0016 20130101; A61F 2220/0075 20130101;
A61F 2250/006 20130101; A61F 2230/0069 20130101; A61F 2250/0039
20130101; A61F 2230/0067 20130101 |
International
Class: |
A61F 2/24 20060101
A61F002/24 |
Claims
1-25. (canceled)
26. A mitral valve prosthesis for implantation at a native mitral
valve complex of a subject, comprising: an inner support structure
having a downstream section, and an upstream section, wherein the
upstream section has a cross-sectional area greater than the
downstream section, the inner support structure being configured to
be positioned at least partially on an atrial side of the native
valve complex, and to apply an axial force directed toward a left
ventricle; and an outer support structure having posterior and
anterior engagement arms configured to be placed over native
leaflets of the native mitral valve complex, wherein the engagement
arms are coupled to the inner support structure, the engagement
arms being configured to define first configurations thereof during
implantation of the prosthesis, and to change shape so as to define
second configurations thereof, subsequent to being placed over the
native leaflets of the native mitral valve complex, each of the
engagement arms spanning a width of less than 12 mm in the first
configuration thereof, and spanning a width of more than 15 mm when
in the second configuration thereof.
27. The mitral valve prosthesis according to claim 26, wherein, in
the first configuration thereof, the engagement arms are configured
to span a width of less than 8 mm.
28. The mitral valve prosthesis according to claim 26, wherein, in
the second configuration thereof, the engagement arms are
configured to span a width of more than 35 mm.
29. The mitral valve prosthesis according to claim 26, wherein, in
the first configuration thereof, the engagement arms are configured
to facilitate functioning of the native valve complex during
implantation of the prosthesis.
30. The mitral valve prosthesis according to claim 26, wherein, in
the first configuration thereof, the engagement arms are configured
to fit between papillary muscles of the native valve complex.
31-40. (canceled)
41. A heart valve prosthesis comprising: a frame comprising: an
expandable inner support structure having a radially compressed
configuration and a radially expanded configuration, the expandable
inner support structure including an inflow section and an outflow
section, wherein in the radially expanded configuration the inflow
section is flared radially outward from the inflow section, wherein
the inflow section in the radially expanded configuration is
asymmetrically shaped such that the inflow portion includes a first
portion and a second portion disposed radially opposite the first
portion, wherein the first portion extends radially farther from a
central longitudinal axis of the heart valve prosthesis than the
second portion, and wherein a first length from an outflow end of
the outflow section to the first portion is longer than a second
length from the outflow end of the outflow section to the second
portion, the first and second lengths being measured parallel to
the central longitudinal axis; and an outer support structure
coupled to the inner support structure; and a valve structure
attached to the frame within an interior area of the inner support
structure.
42. The heart valve prosthesis of claim 41, wherein the inflow
section comprises a plurality of cells.
43. The heart valve prosthesis of claim 42, wherein the outflow
section comprises a plurality of cells.
44. The heart valve prosthesis of claim 41, wherein the outflow
section has a circular cross-section.
45. The heart valve prosthesis of claim 41, wherein the outflow
section is configured to expand within and support against a native
valve annulus.
46. The heart valve prosthesis of claim 41, wherein the outer
support structure includes first and second engagement arms
configured to capture native valve leaflets between the first and
second engagement arms and an outer surface of the inner support
structure.
47. The heart valve prosthesis of claim 46, wherein the outer
support structure includes first and second commissure posts,
wherein the first and second engagement arms are coupled to the
first and second commissure posts.
48. The heart valve prosthesis of claim 41, wherein the inflow
section is configured to expand within and support against an
atrium.
49. The heart valve prosthesis of claim 41, wherein the frame
further comprises fixation barbs attached to the inflow
section.
50. The heart valve prosthesis of claim 41, wherein in the radially
expanded configuration the inflow section is D-shaped.
Description
CROSS REFERENCES TO RELATED APPLICATIONS
[0001] The present application claims the benefit of U.S.
Provisional Application 61/307,743, filed Feb. 24, 2010, entitled,
"Mitral prosthesis and methods for implantation," which is
incorporated herein by reference.
FIELD OF EMBODIMENTS OF THE INVENTION
[0002] Some applications of the present invention generally relate
to implantable medical apparatus. Specifically, some applications
of the present invention relate to apparatus and methods associated
with prosthetic heart valves.
BACKGROUND
[0003] The mitral valve exhibits two types of pathologies:
regurgitation and stenosis. Regurgitation is the more common of the
two defects. Either defect may be treated by surgical repair. Under
certain conditions, the mitral valve must be replaced. Standard
approaches to mitral valve replacement require cutting open the
left side of the heart to access the native mitral valve.
[0004] US 2008/0071368 to Tuval describes a prosthesis for
implantation at a native semilunar valve of a native valve complex.
The prosthesis includes a distal fixation member, configured to be
positioned in a downstream artery, and shaped so as to define
exactly three proximal engagement arms that are configured to be
positioned at least partially within respective ones of semilunar
sinuses, and, in combination, to apply, to tissue that defines the
semilunar sinuses, a first axial force directed toward a ventricle.
The prosthesis further includes a proximal fixation member coupled
to the distal fixation member, the proximal fixation member
configured to be positioned at least partially on a ventricular
side of the native semilunar valve, and to apply, to the
ventricular side of the native valve complex, a second axial force
directed toward the downstream artery, such that application of the
first and second forces couples the prosthesis to the native valve
complex.
[0005] US 2009/0276040 to Rowe describes a prosthetic mitral valve
assembly and method of inserting the same. In certain embodiments,
the prosthetic mitral valve assembly has a flared upper end and a
tapered portion to fit the contours of the native mitral valve. The
prosthetic mitral valve assembly can include a stent or outer
support frame with a valve mounted therein. The assembly is
described as being adapted to expand radially outwardly and into
contact with the native tissue to create a pressure fit. One
embodiment is described including positioning the mitral valve
assembly below the annulus such that the annulus itself can
restrict the assembly from moving in an upward direction towards
the left atrium. The mitral valve assembly is also described as
being positioned so that the leaflets of the mitral valve hold the
assembly to prevent downward movement of the assembly towards the
left ventricle.
[0006] US 2010/0217382 to Chau describes a prosthetic mitral valve
assembly and method of inserting the same. In certain embodiments,
the prosthetic mitral valve assembly includes a stent and valve
combination. The stent is designed so that the anchoring portion is
positioned above the annulus of the mitral valve and in the left
atrium. The stent is radially expandable so that it can expand into
position against the walls of the left atrium and accommodate a
wide range of anatomies. Contact between the stent and the native
tissue in the left atrium is described as reducing paravalvular
leakage and preventing migration of the stent once in place.
[0007] US 2009/0005863 to Goetz describes a replacement valve for
implantation centrally within the orifice of a malfunctioning
native heart valve. The valve is designed for minimally invasive
entry through an intercostal opening in the chest of a patient and
an opening in the apex of the human heart. The replacement valve
includes either a separate anchor or a combined anchor that folds
around the malfunctioning native valve leaflets, sandwiching them
in a manner so as to securely anchor the replacement valve in a
precise, desired location.
[0008] US 2009/0216312 to Straubinger describes a stent for the
positioning and anchoring of a valvular prosthesis in an
implantation site in the heart of a patient. Specifically, the
Straubinger application relates to an expandable stent for an
endoprosthesis used in the treatment of a narrowing of a cardiac
valve and/or a cardiac valve insufficiency. The stent is described
as comprising at least one fastening portion via which the valvular
prosthesis is connectable to the stent, so as to ensure that no
longitudinal displacement of a valvular prosthesis fastened to a
stent will occur relative the stent in the implanted state of the
stent, even given the peristaltic motion of the heart. The stent
further comprises positioning arches and retaining arches, whereby
at least one positioning arch is connected to at least one
retaining arch via a first connecting web. The stent moreover
comprises at least one auxiliary retaining arch which connects the
respective arms of the at least one retaining arch connected to the
at least one positioning arch.
[0009] US 2008/0255660 to Guyenot describes a medical device for
treating a heart valve insufficiency, with an endoprosthesis which
can be introduced into a patient's body and expanded to secure a
heart valve prosthesis in the patient's aorta. In an embodiment,
the endoprosthesis has a plurality of positioning arches configured
to be positioned with respect to a patient's aorta and a plurality
of retaining arches to support a heart valve prosthesis. The
endoprosthesis includes a first collapsed mode during the process
of introducing it into the patient's body and a second expanded
mode when it is implanted.
[0010] The following references may be of interest: [0011] US
2010/0030330 to Bobo [0012] US 2009/0216313 to Straubinger [0013]
US 2009/0216310 to Straubinger [0014] US 2008/0255661 to
Straubinger [0015] US 2008/0208328 to Antocci [0016] US
2008/0071369 to Tuval [0017] US 2008/0071363 to Tuval [0018] US
2008/0071366 to Tuval [0019] US 2008/0071362 to Tuval [0020] US
2008/0071361 to Tuval [0021] US 2003/0036791 to Bonhoeffer [0022]
WO 04/019825 to Figulla
SUMMARY OF EMBODIMENTS
[0023] For some applications of the present invention, mitral valve
prostheses and methods for implanting the prostheses are provided.
The prostheses are typically implanted transcatheterally, for
example, transapically (i.e., through the apex of the heart),
transatrially (i.e., through the left atrium of the heart), and/or
transseptally (i.e., through the septum of the heart). The
prostheses typically include inner and outer support structures,
the outer support structure including engagement arms. A valve
prosthesis is typically sutured to the inner support structure.
[0024] Typically, the prostheses are placed on the native mitral
valve complex such that the native leaflets are disposed between
the inner support structure and the engagement arms. For some
applications, such a configuration prevents the native leaflets
from obstructing flow through the left ventricular outflow tract
(LVOT), prevents the native leaflets from interacting with the
prosthetic leaflets, recruits the native leaflets in minimizing
peri-valvular leaks, maintains proper alignment of the valve
prosthesis, avoids systolic anterior mobility, and/or maintains
valve stability by preventing migration of the valve into the
atrium or ventricle. For some applications, the design of the
prosthesis is similar to the native valve and supports a non-round
in vivo configuration, which reflects native valve function.
[0025] There is therefore provided, in accordance with some
applications of the present invention, apparatus including a mitral
valve prosthesis for implantation at a native mitral valve complex
of a subject, the prosthesis including:
[0026] an inner support structure having a downstream section and
an upstream section, the upstream section having a cross-sectional
area greater than the downstream section, the inner support
structure being configured to be positioned at least partially on
an atrial side of the native valve complex, and to prevent the
prosthesis from being dislodged into a left ventricle by applying
an axial force directed toward the left ventricle;
[0027] a prosthetic valve having prosthetic valve leaflets coupled
to the inner support structure; and
[0028] an outer support structure having two or more engagement
arms, downstream ends of the engagement arms being coupled to the
inner support structure,
[0029] the prosthesis being configured such that, upon implantation
thereof: [0030] downstream ends of native valve leaflets of the
native mitral valve complex, [0031] the downstream ends of the
engagement arms, and [0032] downstream ends of the prosthetic
leaflets,
[0033] are disposed at a longitudinal distance from one another of
less than 3 mm, the longitudinal distance being measured in a
direction of a longitudinal axis of the prosthesis.
[0034] For some applications, the downstream ends of the engagement
arms are coupled to the inner support structure within 3 mm of a
downstream end of the inner support structure.
[0035] For some applications, the prosthesis is configured such
that, upon implantation thereof, no portion of the prosthesis
protrudes into a left ventricle of the subject by more than 3
mm.
[0036] For some applications, the engagement arms are integrally
formed with the inner support structure.
[0037] For some applications, the prosthesis is configured such
that, upon implantation thereof: [0038] the downstream ends of
native valve leaflets of the native mitral valve complex, [0039]
the downstream ends of the engagement arms, and [0040] the
downstream ends of the prosthetic leaflets,
[0041] are disposed at a longitudinal distance from one another of
less than 1 mm, the longitudinal distance being measured in a
direction of a longitudinal axis of the prosthesis.
[0042] For some applications, the prosthesis is configured such
that, upon implantation thereof, no portion of the prosthesis
protrudes into a left ventricle of the subject by more than 1
mm.
[0043] For some applications, the downstream ends of the engagement
arms are coupled to the inner support structure within 1 mm of a
downstream end of the inner support structure.
[0044] For some applications, for each engagement arm, along at
least 30% of a length of the engagement arm, the engagement arm is
at a distance of at least 0.5 mm from an outer surface of the inner
support structure.
[0045] For some applications, the distance is at least 1 mm.
[0046] For some applications, the distance is at least 4 mm.
[0047] For some applications, the engagement arm is at the distance
from the outer surface of the inner support structure along at
least 50% of the length of the engagement arm.
[0048] For some applications, the engagement arm is at the distance
from the outer surface of the inner support structure along at
least 70% of the length of the engagement arm.
[0049] For some applications, the outer support structure further
includes a connecting frame, the connecting frame of the outer
support structure being configured to be coupled to the inner
support structure.
[0050] For some applications, the inner support structure is shaped
to define a plurality of cells, and the connecting frame of the
outer support structure is shaped to define a plurality of cells
having shapes and sizes that match cells of the inner support
structure.
[0051] For some applications, the prosthesis is configured, upon
implantation thereof, to reduce motion of the native valve
leaflets, by holding the leaflets inside the engagement arms.
[0052] For some applications, the prosthesis is configured to
immobilize the native valve leaflets, by holding the leaflets
inside the engagement arms.
[0053] For some applications, the prosthesis is configured to
prevent systolic anterior motion of the native valve leaflets, by
holding the leaflets inside the engagement arms.
[0054] For some applications, the prosthesis is configured to
prevent the native leaflets from interfering with LVOT, by holding
the leaflets inside the engagement arms.
[0055] For some applications, the outer support structure further
includes covers for covering the engagement arms, the covers being
configured to reduce the motion of the native leaflets.
[0056] There is further provided, in accordance with some
applications of the present invention apparatus including a mitral
valve prosthesis for implantation at a native mitral valve complex
of a subject, the prosthesis including:
[0057] an inner support structure having a downstream section, and
an upstream section, wherein the upstream section has a
cross-sectional area greater than the downstream section, the inner
support structure being configured to be positioned at least
partially on an atrial side of the native valve complex, and to
apply an axial force directed toward a left ventricle; and
[0058] an outer support structure having posterior and anterior
engagement arms configured to be placed over, respectively,
posterior and anterior leaflets of the native mitral valve complex,
wherein the engagement arms are coupled to the inner support
structure,
[0059] wherein a ratio of a length of the anterior engagement arm
to a length of the posterior arm is between 1.1:1 and 15:1.
[0060] For some applications, the ratio is between 1.3:1 and
2:1.
[0061] For some applications, the length of the anterior engagement
arm is between 2 mm and 35 mm.
[0062] For some applications, the length of the anterior engagement
arm is between 15 mm and 25 mm.
[0063] For some applications, the length of the posterior
engagement arm is between 2 mm and 35 mm.
[0064] For some applications, the length of the posterior
engagement arm is between 7 mm and 23 mm.
[0065] There is additionally provided, in accordance with some
applications of the present invention, apparatus including a mitral
valve prosthesis for implantation at a native mitral valve complex
of a subject, the prosthesis including:
[0066] an inner support structure having a downstream section, and
an upstream section, wherein the upstream section has a
cross-sectional area greater than the downstream section, the inner
support structure being configured to be positioned at least
partially on an atrial side of the native valve complex, and to
apply an axial force directed toward a left ventricle; and
[0067] an outer support structure having posterior and anterior
engagement arms configured to be placed over native leaflets of the
native mitral valve complex, wherein the engagement arms are
coupled to the inner support structure,
[0068] the engagement arms being configured to define first
configurations thereof during implantation of the prosthesis, and
to change shape so as to define second configurations thereof,
subsequent to being placed over the native leaflets of the native
mitral valve complex,
[0069] each of the engagement arms spanning a width of less than 12
mm in the first configuration thereof, and spanning a width of more
than 15 mm when in the second configuration thereof.
[0070] For some applications, in the first configuration thereof,
the engagement arms are configured to span a width of less than 8
mm.
[0071] For some applications, in the second configuration thereof,
the engagement arms are configured to span a width of more than 35
mm.
[0072] For some applications, in the first configuration thereof,
the engagement arms are configured to facilitate functioning of the
native valve complex during implantation of the prosthesis.
[0073] For some applications, in the first configuration thereof,
the engagement arms are configured to fit between papillary muscles
of the native valve complex.
[0074] There is additionally provided in accordance with some
applications of the present invention apparatus including a mitral
valve prosthesis for implantation at a native mitral valve complex
of a subject, the prosthesis including:
[0075] an inner support structure having a downstream section and
an upstream section, the upstream section having a cross-sectional
area greater than the downstream section, the inner support
structure being configured to be positioned at least partially on
an atrial side of the native valve complex, and to prevent the
prosthesis from being dislodged into a left ventricle by applying
an axial force directed toward the left ventricle;
[0076] an outer support structure having two or more engagement
arms, downstream ends of the engagement arms being coupled to the
inner support structure, and
[0077] a prosthetic valve having prosthetic valve leaflets coupled
to the inner support structure such that downstream ends of the
prosthetic valve leaflets are within 3 mm of the downstream ends of
the engagement arms;
[0078] a longitudinal distance from a downstream end to an upstream
end of each of the engagement arms being less than 18 mm, the
longitudinal distance being measured in a direction of a
longitudinal axis of the prosthesis.
[0079] For some applications, the prosthetic valve leaflets are
coupled to the inner support structure such that downstream ends of
the prosthetic valve leaflets are within 1 mm of the downstream
ends of the engagement arms.
[0080] For some applications, the longitudinal distance from the
downstream end to the upstream end of each of the engagement arms
is less than 12 mm.
[0081] For some applications, the longitudinal distance from the
downstream end to the upstream end of each of the engagement arms
is less than 10 mm.
[0082] For some applications, the downstream ends of the engagement
arms are coupled to the inner support structure within 3 mm of a
downstream end of the inner support structure.
[0083] For some applications, the downstream ends of the engagement
arms are coupled to the inner support structure within 1 mm of a
downstream end of the inner support structure.
[0084] There is further provided, in accordance with some
applications of the present invention apparatus including a mitral
valve prosthesis for implantation at a native mitral valve complex
of a subject, the prosthesis including:
[0085] an inner support structure having a downstream section and
an upstream section, the upstream section having a cross-sectional
area greater than the downstream section, the inner support
structure being configured to be positioned at least partially on
an atrial side of the native valve complex, and to prevent the
prosthesis from being dislodged into a left ventricle by applying
an axial force directed toward the left ventricle;
[0086] a prosthetic valve having prosthetic valve leaflets coupled
to the inner support structure; and
[0087] an outer support structure having two or more engagement
arms, the engagement arms being coupled to the inner support
structure,
[0088] the prosthesis being configured such that, upon implantation
thereof: [0089] downstream ends of native valve leaflets of the
native mitral valve complex, and downstream ends of the engagement
arms are disposed at a longitudinal distance from one another of
less than 3 mm, the longitudinal distance being measured in a
direction of a longitudinal axis of the prosthesis, and [0090] a
downstream end of the inner support structure and downstream ends
of the prosthetic valve leaflets are at a longitudinal distance of
at least 4 mm upstream of the downstream ends of the native valve
leaflets, the longitudinal distance being measured in a direction
of a longitudinal axis of the prosthesis.
[0091] For some applications, the prosthesis is configured such
that, upon implantation thereof, the downstream end of the inner
support structure and the downstream ends of the prosthetic valve
leaflets are at a longitudinal distance of at least 10 mm upstream
of the downstream ends of the native valve leaflets.
[0092] There is additionally provided in accordance with some
applications of the present invention apparatus including a mitral
valve prosthesis for implantation at a native mitral valve complex
of a subject, the prosthesis including:
[0093] an inner support structure having a downstream section and
an upstream section, the upstream section having a cross-sectional
area greater than the downstream section, the inner support
structure being configured to be positioned at least partially on
an atrial side of the native valve complex, and to prevent the
prosthesis from being dislodged into a left ventricle by applying
an axial force directed toward the left ventricle;
[0094] an outer support structure having two or more engagement
arms, the engagement arms being coupled to the inner support
structure, and
[0095] a prosthetic valve having prosthetic valve leaflets coupled
to the inner support structure such that downstream ends of the
prosthetic valve leaflets are at least 4 mm upstream of the
downstream ends of the engagement arms.
[0096] For some applications, the prosthetic valve leaflets are
coupled to the inner support structure such that the downstream
ends of the prosthetic valve leaflets are at least 10 mm upstream
of the downstream ends of the engagement arms.
[0097] The present invention will be more fully understood from the
following detailed description of embodiments thereof, taken
together with the drawings, in which:
BRIEF DESCRIPTION OF THE DRAWINGS
[0098] FIGS. 1A-D are schematic illustration of respective views of
a mitral valve prosthesis, in accordance with some applications of
the present invention;
[0099] FIGS. 2A-D are schematic illustrations of respective views
of a mitral valve prosthesis, in accordance with some applications
of the present invention;
[0100] FIG. 3 is a schematic illustration of an inner expandable
support structure of the prosthesis, in accordance with some
applications of the present invention;
[0101] FIGS. 4A-F are schematic illustrations of mitral prostheses,
in accordance with some applications of the present invention;
[0102] FIGS. 5A-B are schematic illustrations of the inner
expandable support structure of the prosthesis, in accordance with
some applications of the present invention;
[0103] FIGS. 6A-D are schematic illustrations of the inner
expandable support structure of the prosthesis, in accordance with
some applications of the present invention;
[0104] FIGS. 7A-F are schematic illustrations of respective steps
of a transapical implantation procedure of the mitral valve
prosthesis, in accordance with some applications of the present
invention;
[0105] FIGS. 8A-F are schematic illustrations of respective steps
of a transatrial implantation procedure of the mitral valve
prosthesis, in accordance with some applications of the present
invention;
[0106] FIG. 9 is a schematic illustration of an implanted mitral
valve prosthesis, in accordance with some applications of the
present invention;
[0107] FIGS. 10A-D are schematic illustrations of the engagement
arms of the mitral valve prosthesis, in accordance with respective
applications of the present invention;
[0108] FIGS. 11A-D are schematic illustrations of an engagement arm
assembly, in accordance with some applications of the present
invention;
[0109] FIG. 12 is a schematic illustration of the mitral valve
prosthesis, in accordance with some applications of the present
invention;
[0110] FIG. 13 is a schematic illustration of the mitral valve
prosthesis, in accordance with some applications of the present
invention;
[0111] FIGS. 14A-B are schematic illustrations of the mitral valve
prosthesis, in accordance with some applications of the present
invention; and
[0112] FIGS. 15A-B are schematic illustrations of the mitral valve
prosthesis, in accordance with some applications of the present
invention.
DETAILED DESCRIPTION OF EMBODIMENTS
[0113] Reference is now made to FIGS. 1A-D, which are schematic
illustrations of respective views of a mitral valve prosthesis 100,
in accordance with some applications of the present invention.
[0114] Mitral valve prosthesis 100 includes an inner support
structure 102 and an outer support structure 104. Outer support
structure 104 includes outer engagement arms (i.e., outer support
arms) 106. As shown, mitral valve prosthesis 100 typically includes
two outer engagement arms 106 to anatomically match the native
mitral valve leaflets 107 (shown in FIG. 1B).
[0115] Sutured to inner support structure 102 is a prosthetic valve
118. For some applications, valve 118 is coupled to inner support
structure 102, and/or to engagement arms 106 in accordance with
techniques described in US 2008/0071368 to Tuval, which is
incorporated herein by reference. Valve 118 can be formed of a
biocompatible synthetic material, synthetic polymer, an autograft
tissue, xenograft tissue, or other alternative materials. Valve 118
is a bi-leaflet bovine pericardium valve, a tri-leaflet valve, or
any other suitable valve (e.g., a valve having a different number
of leaflets).
[0116] Mitral-valve prosthesis 100 is typically placed at the
subject's native mitral valve complex 128, as shown in FIG. 1D. As
used herein, including in the claims, the "native mitral valve
complex" includes the native valve leaflets, the annulus of the
valve, chordae tendineae, and papillary muscles. Inner support
structure 102 and engagement arms 106 facilitate fixation of the
mitral valve prosthesis with respect to native mitral valve complex
128. Prosthetic valve 118 functions in a generally similar manner
to a healthy native mitral valve, i.e., the prosthetic valve:
[0117] opens during diastole to permit the flow of blood from the
subject's left atrium to the subject's left ventricle, and [0118]
closes during systole to prevent the backflow of blood in the
upstream direction from the subject's left ventricle to the
subject's left atrium.
[0119] FIG. 1C shows prosthetic valve 118 in a closed state thereof
(i.e., during systole). The prosthetic valve shown in FIG. 1C has
three leaflets, although as described hereinabove, for some
applications, valve 118 has a different number of leaflets.
[0120] As shown in FIG. 1B, upon implantation, mitral valve
prosthesis 100 is placed such that native mitral valve leaflets 107
are disposed between outer engagement arms 106 and inner support
structure 102. The outer engagement arms embrace, without
squeezing, leaflets of the native valve. Typically there is a space
between the engagement arms and the inner support structure, such
that native valve leaflets are not squeezed. For example, along at
least 30% of length L of the engagement arm, the engagement arm is
separated from the inner support structure by a distance D of at
least 0.5 mm. For some applications, the engagement arm is
separated from the inner support structure by a distance D of at
least 0.5 mm along at least 50% or 70% of length L of the
engagement arm. For some applications, the aforementioned distance
D by which the engagement arm is separated from the inner support
structure is greater than 1 mm or greater than 4 mm.
[0121] Each outer engagement arm 106 is typically downwardly
concave (i.e., concave in a downstream direction) at the region of
the outer engagement arm that is adjacent to a downstream section
112 of inner support structure 102, when viewed from outside of the
outer support structure, as shown in FIG. 1B, for example. The
downstream ends of the engagement arms typically meet at commissure
posts 108 (shown in FIG. 1A). For some applications, the engagement
arms are coupled to the inner support structure at the commissure
posts. Alternatively or additionally, the engagement arms, and/or
the inner support structure is coupled to prosthetic valve 118 at
the commissure posts, for example, in accordance with techniques
described in US 2008/0071368 to Tuval, which is incorporated herein
by reference. For some applications, mitral valve prosthesis 100
includes three engagement arms 106, three leaflets, and/or three
commissure posts 108, or a different number of the aforementioned
components.
[0122] Typically, engagement arms 106 facilitate the anchoring
and/or orientation of the mitral valve prosthesis at the desired
implantation site. In particular, the engagement arms prevent
mitral valve prosthesis 100 from being dislodged upstream of native
mitral valve complex 128 (e.g., when valve 118 is closed during
systole and an upstream force is exerted on prosthesis 100). This
is achieved, because, in response to upstream-directed blood flow
pushing the valve prosthesis in the upstream direction (e.g.,
during systole), tissue of leaflets 107 of the native mitral valve
complex exerts a downstream-directed force F1 (shown in FIG. 1B) on
the engagement arms. For some applications (e.g., for the
configuration of prosthesis 100 shown in FIGS. 4E-F), downstream
ends of the native valve leaflets exert the downstream directed
force on downstream portions of the engagements arms, i.e., at the
portion of the engagement arms at which the engagement arms form
shoulders with inner support structure 102.
[0123] Typically, downstream ends 105 of engagement arms 106 are
within 3 mm (e.g., within 1 mm) of downstream ends 119 of
prosthetic leaflets 118 (see FIG. 1A), when measured in the
direction of the longitudinal axis of the prosthesis. Further
typically, upon implantation of the prosthesis, downstream ends 105
of engagement arms 106 are within 3 mm (e.g., within 1 mm) of
downstream ends of the native valve leaflets 107 (see FIG. 1B).
Thus, downstream ends of the engagement arms, downstream ends of
the native valve leaflets, and downstream ends of the prosthetic
valve leaflets are all typically within 3 mm (e.g., within 1 mm) of
each other, when measured in the direction of the longitudinal axis
of the prosthesis. Typically, this is achieved because (a) the
prosthetic valve leaflets are coupled to the inner support
structure such that downstream ends of the prosthetic valve
leaflets are within 3 mm (e.g., within 3 mm) of the downstream ends
of the engagement arms, and (b) longitudinal distance D1 (shown in
FIG. 1B) from a downstream end 105 to an upstream end 109 of each
of the engagement arms is less than 18 mm (e.g., less than 12 mm,
or less than 10 mm), the longitudinal distance being measured in a
direction of a longitudinal axis of the prosthesis. Further
typically, the downstream ends of the engagement arms are coupled
to the inner support structure within 3 mm (e.g., within 1 mm) of a
downstream end of the inner support structure.
[0124] Inner support structure 102 includes a downstream section
112, and an upstream section 116. Inner support structure 102 is
typically non-cylindrical. In accordance with respective
applications, downstream section 112 of inner support structure 102
is formed in a straight fashion (i.e., cylindrical and parallel to
the longitudinal axis of prosthesis 100), or in a flared fashion
(i.e., diverging away from the longitudinal axis of prosthesis
100). Upstream section 116 of the inner support structure typically
curves outwardly from the longitudinal axis of the prosthesis, such
that the upstream section has a cross-sectional area that is
greater than the cross-sectional area of downstream section 116.
The upstream section of the inner support structure is typically
wider than the native valve segment at the native annular
level.
[0125] Typically, the non-cylindrical shape of the inner support
structure facilitates the anchoring and/or orientation of the
mitral valve prosthesis at the desired implantation site. In
particular, the upstream section of the inner support structure
being wider than the native valve segment at the native annular
level prevents the mitral valve prosthesis from being dislodged
downstream of native mitral valve complex 128. This is achieved,
because in response to downstream-directed blood flow pushing the
valve prosthesis in a downstream direction, tissue of native mitral
valve complex 128 exerts an upstream-directed force F2 (shown in
FIG. 1B) on the upstream section of the inner support
structure.
[0126] For some applications, the upstream section of the inner
support structure being wider than the native valve segment at the
native annular level improves sealing of prosthesis 100 against the
atrial wall. For some applications, the inner support structure
additionally exerts a radially-directed force on tissue of native
mitral valve complex 128 that facilitates the anchoring and/or
orientation of the prosthetic valve at the desired implantation
site. For some applications, upstream section 116 of the inner
support structure exerts the radially-directed force on tissue of
native mitral valve complex 128.
[0127] Typically, when valve prosthesis 100 is implanted in native
mitral valve complex 128, there are variations with time in the
mechanical stress exerted on the inner support structure, caused by
anatomical and pathological variations of surrounding structures.
For some applications, relative to a more cylindrically-shaped
inner support structure, non-cylindrical inner support structure
resists changes in its shape due to mechanical stress that is
exerted on the inner support structure. Typically, by resisting
changes in its shape, the inner support structure facilitates the
proper functioning of prosthetic valve 118.
[0128] Typically, inner support structure 102 is expandable (e.g.,
self-expandable). For example, the inner support structure may be
formed of a memory alloy, such as nitinol, or another biocompatible
metal. Similarly, outer support structure 104 may be formed of a
memory alloy, such as nitinol, or another biocompatible metal. In
accordance with respective applications, inner support structure
102 and outer support structure 104 are integrally formed, or
comprise separate modular components that are attached to one
another, as described in further detail hereinbelow.
[0129] For some applications, inner support structure 102 is
designed to flex and deform in response to the natural cardiac
movements of the heart through the cardiac cycle. Alternatively,
inner support structure 102 is generally rigid, to avoid flexing or
deformation during the cardiac cycle.
[0130] For some applications, inner support structure 102 includes
one or more sections that are configured to expand to a restricted
or preset diameter rather than expanding until restrained by
surrounding anatomical structures. Thus, a portion of (or the
entirety of) inner support structure 102 may have a predetermined
configuration, irrespective of the surrounding anatomy. Typically,
the predetermined configuration is such that the support structure
expands so as to come into contact with the tissue of the native
valve complex, but does not exert substantial pressure on the
tissue of the native valve complex. For some applications, the
controlled expansion diameter of the inner support structure
improves the valve geometry, relative to a mitral valve prosthesis
having an inner support structure that expands until restrained by
the surrounding anatomy. Typically, at least a portion of inner
support structure 102 (and further typically, all of the inner
support structure) expands until restrained by the surrounding
anatomy.
[0131] As shown (in FIGS. 1A, 1C and 1D, for example), for some
applications, downstream section 112 and upstream section 116 of
inner support structure 102 include generally-diamond-shaped cells
103, which are described in further detail hereinbelow, with
reference to FIG. 3. Alternatively, other shapes and configurations
of the cells 103 are employed, for example, as described
hereinbelow. For some applications, the locations of junctions of
members of a cell with those of adjacent cells are positioned
asymmetrically, and/or cells are shaped asymmetrically. For some
applications, structural members of the cells are shaped
curvilinearly. Alternatively, structural members of the cells are
formed in a generally zigzag configuration to form symmetrical or
asymmetrical cells. For some applications, using structural members
that are shaped in a zigzag configuration distributes the stress
associated with radial expansion and contraction of the support
member to a plurality of points between junctions. In accordance
with respective applications, the inner support structure includes
heterogeneous patterns of cells, or homogeneous patterns, or
both.
[0132] Typically, the ratio of the cell height (H) to cell width
(W) (H and W shown in FIGS. 1A and 1C) of cells 103 is greater than
0.5:1 and/or less than 3:1, e.g., 0.5:1 to 3:1. For example, the
ratio may be greater than 1.5:1 and/or less than 2.5:1, e.g. 1.5:1
to 2.5:1. For example, the ratio may be greater than 1.75:1 and/or
less than 2.25:1, e.g., 1.75:1 to 2.25:1. For some applications,
having cells having the aforementioned ratios of cell height to
cell width facilitates the expansion and/or the maintenance of the
structure of inner support structure 102.
[0133] Reference is now made to FIGS. 2A-D, which are schematic
illustrations of respective views of mitral valve prosthesis 100,
in accordance with some applications of the present invention. For
some applications, a length L2 (shown in FIG. 2B) of an anterior
engagement arm 106A is greater than a length L3 of a posterior
engagement arm 106P. For some applications, the different lengths
of the anterior and posterior engagement arms correspond to the
anatomy of most people, most people having a native anterior mitral
valve leaflet having a greater length than their native posterior
mitral valve leaflet. In all other aspects, the mitral valve
prosthesis shown in FIGS. 2A-D is generally similar to the mitral
valve prosthesis described with reference to FIGS. 1A-D.
[0134] Typically, length L2 of the anterior engagement arm is
greater than 2 mm and less than 35 mm, e.g., 15 mm to 25 mm.
Further typically, length L3 of the posterior engagement arm is
greater than 2 mm and less than 35 mm, e.g., 7 mm to 23 mm. Still
further typically, for applications in which the anterior and
posterior engagement arms have different lengths, the ratio of the
length of the anterior engagement arm to the length of the
posterior engagement arm is greater than 1.1:1, and/or less than
15:1, e.g., 1.3:1 to 2:1.
[0135] Reference is now made to FIG. 3, which is a schematic
illustration of inner support structure 102 of mitral valve
prosthesis 100, in accordance with some applications of the present
invention. As shown in FIG. 3, for some applications, cells 103 of
the inner support structure have respective characteristics at
different longitudinal locations along the inner support
structure.
[0136] For some applications, downstream section 112 of the inner
support structure includes cells that have relatively short
heights, and relatively high strut width relative to height. In
addition, the cells typically define relatively high angles. For
some applications, cells having the aforementioned characteristics
provide the downstream section of the support structure with a high
radial force area to maintain circularity of the valve, and/or
fatigue resistance against high pressure gradients. Typically, the
downstream section of the support structure is relatively short, so
as to minimize protrusion of the inner support structure into the
ventricle beyond the annular plane.
[0137] For some applications, upstream section 116 of inner support
structure includes an intermediate section 116A, and an
upstream-most section 116B, intermediate section 116B being
disposed between upstream-most section 116A and downstream section
112 of the support structure. The cells of intermediate section
116A and upstream-most section 116B have respective
characteristics.
[0138] Cells 103 of intermediate section 116A typically have
relatively short heights, and relatively high strut width relative
to height. In addition, the cells typically define relatively high
angles. For some applications, cells having the aforementioned
characteristics provide the intermediate section of the support
structure with high pinching resistance. The intermediate section
of the support structure is typically shaped so as to facilitate
annular sealing on the atrial side of the mitral valve complex,
above the annulus. Alternatively or additionally, the intermediate
section of the support structure is shaped so as to prevent
downstream migration of mitral valve prosthesis 100.
[0139] Cells 103 of upstream-most section 116B typically have large
heights. The shape of the cells of the upstream-most portion
typically exert relatively low radial pressure on the surrounding
anatomy, such that the upstream-most section of the support
structure enhances sealing of the native valve complex, by
conforming to the atrial anatomy. Furthermore, by conforming to the
atrial anatomy, the upstream-most section preserves atrial
contraction. The upstream-most section of the support structure
typically has a relatively large cross-sectional area, which
typically prevents downstream migration of mitral valve prosthesis
100.
[0140] Reference is now made to FIGS. 4A-F, which are schematic
illustrations of mitral prosthesis 100, in accordance with some
applications of the present invention. As shown in FIGS. 4A-D, for
some applications, inner support structure 102 of mitral valve
prosthesis 100 does not extend to the downstream end of the
prosthesis. For example, as shown, the inner support structure may
extend from an upstream end 120 to substantially halfway between
upstream and downstream ends of the prosthesis, such that the
downstream end of the inner support structure is between 2 mm and
15 mm from downstream ends 119 of prosthetic leaflets 118.
Alternatively, inner support structure 102 of mitral valve
prosthesis 100 does extend substantially to the downstream end of
the prosthesis, for example, such that the downstream end of the
inner support structure is within 1 mm of downstream ends 119 of
prosthetic leaflets 118 (a shown in FIG. 1C, for example).
[0141] For some applications, outer support structure 104 includes
outer engagement arms 106 that are coupled to upstream ends of
commissure post 108, rather than being coupled to downstream ends
of the commissure posts, as described with reference to FIGS. 1A-D.
As shown in FIG. 4B, for some applications, commissure post 108
extends downstream from the ends of engagement arms 106. For such
applications, the downstream ends of commissure posts 108 are level
with the ends of prosthetic valve leaflets 118. In all other
respects, prosthesis 100 of FIG. 4B is generally similar to
prosthesis 100 as described hereinabove with reference to FIGS.
1-3.
[0142] For some applications, not having the inner support
structure extend to the downstream end of the prosthesis, allows
for prosthesis 200 to be constructed of less material, and/or
reduces the weight of prosthesis 200.
[0143] As shown in FIGS. 4E-F, for some applications, engagement
arms 106 and prosthetic valve 118 are coupled to inner support
structure 102 such that downstream ends 119 of the prosthetic valve
leaflets are at a longitudinal distance D2 upstream of the
downstream ends 105 of the engagement arms. Thus, prosthesis 100 is
configured such that upon implantation thereof, the downstream end
of the inner support structure 102 and downstream ends 119 of the
prosthetic valve leaflets 118 are at a longitudinal distance D2
upstream of the downstream ends of the native valve leaflets 107.
Typically, distance D2 is at least 4 mm, e.g., at least mm. Further
typically, upon implantation of the prosthesis, downstream ends of
native valve leaflets of the native mitral valve complex, and
downstream ends 105 of the engagement arms are disposed at a
longitudinal distance from one another of less than 3 mm.
[0144] Reference is now made to FIGS. 5A-B, which are schematic
illustrations of inner expandable support structure 104 of mitral
valve prosthesis 100, in accordance with some applications of the
present invention. As shown, for some applications, apices of the
inner support structure at the upstream end of the support
structure are rounded. FIG. 5B shows slightly rounded apices, and
FIG. 5A shows more rounded apices. For some applications, using
apices that are rounded reduces trauma to the atrial endocardium,
and/or enhances local radial stiffness of the inner support
structure, relative to using an inner support structure having a
non-rounded upstream end. For some applications, the downstream end
of the inner support structure also has rounded cell-apices. In
alternative applications, the apices of the cells at the downstream
end of the inner support structure are non-rounded (as shown in
FIGS. 5A-B), or the apices of the cells at both ends of the inner
support structure are non-rounded (as shown in FIG. 1A).
[0145] Reference is now made to FIGS. 6A-D, which are schematic
illustrations of inner expandable support structure 102 of
prosthesis 100, in accordance with some applications of the present
invention.
[0146] Prosthesis 100 shown in FIGS. 6A-B is generally similar to
the prosthesis described hereinabove, the prosthesis including
inner support structure 102 and outer support structure 104.
However, the shape of inner support structure 102 differs from the
shape of inner support structure 102 of FIG. 1A. Specifically,
upstream section 116 of inner support structure 102 is formed
asymmetrically to accommodate the anterior horn of the atrium
(which is associated anatomically with the position of the aortic
valve), as shown in FIG. 6B, which shows the prosthesis implanted
inside the subject's heart. For example, as shown in FIG. 6A, the
length of prosthesis 100 from downstream section 112 to upstream
section 116 is increased at an area corresponding to the anterior
horn of the atrium. This area also extends radially farther from
the longitudinal axis of the prosthesis, in order to accommodate
the anterior horn. As described hereinabove, upstream section 116
is generally wider than the native valve segment at the native
annular level. Such a configuration prevents migration of
prosthesis 100 into the ventricle and improves sealing of
prosthesis 100 against the atrial wall.
[0147] For some applications, as shown, downstream section 112 of
the inner support structure has a circular cross-section, while
upstream section 116 has a non-circular cross-section. Typically,
for applications in which inner support structure is shaped to
accommodate the anterior horn of the atrium, the cross-section of
inner support structure 102 is a non-uniform, non-circular shape,
for example, a D-shape, or oval.
[0148] FIG. 6B is a sagittal cut through a human heart 124
depicting the implanted mitral valve prosthesis 100 of FIG. 6A.
Chordae tendineae 126, which are disposed in left ventricle 127,
connect native mitral valve 128 to papillary muscles 130.
Engagement arms 106 wrap around leaflets 107 of native mitral valve
128. As shown in FIG. 6B, upstream section 116 has a non-circular,
asymmetric shape to accommodate the anterior horn of atrium 132,
which is associated anatomically with the position of aortic valve
134. The shape of upstream section 116 facilitates axial fixation,
facilitates prevention of outflow obstruction, and/or facilitates
sealing of prosthesis 100 against the wall of left atrium 132.
[0149] Prosthesis 100 shown in FIGS. 6C-D is generally similar to
the prosthesis described hereinabove, the prosthesis including
inner support structure 102 and outer support structure 104.
However, in accordance with some applications of the invention,
upstream section 116 of the inner support structure includes
fixation members 190 (e.g., barbs, as shown, hooks, anchors, or
clips) to provide further fixation support and to prevent migration
of prosthesis 100 into the ventricle.
[0150] FIG. 6D is a sagittal cut through a human heart 124,
depicting an implanted mitral valve prosthesis 100. As shown in
FIG. 6D, upstream section 116 has a non-circular, asymmetric shape
to accommodate the anterior horn of left atrium 132. The shape of
upstream section 116 facilitates axial fixation, facilitates
prevention of outflow obstruction, and/or facilitates sealing of
prosthesis 100 against the wall of left atrium 132. Further, barbs
190 penetrate to the mitral annulus and serve as a locking
mechanism to prevent migration of prosthesis 100 into left
ventricle 127.
[0151] Reference is now made to FIGS. 7A-F, which are schematic
illustrations of respective steps of a transapical implantation
procedure of mitral valve prosthesis 100 (described hereinabove
with reference to any of FIGS. 1-6), in accordance with some
applications of the present invention.
[0152] As shown in FIG. 7A, a trocar (i.e., an overtube) 730 is
inserted into the left ventricle 127 through an incision created in
the apex 724 of a patient's heart 124. A dilator 732 is used to aid
in the insertion of trocar 730. In this transapical approach, the
native mitral valve 128 is approached from the downstream
direction. As shown in FIG. 7B, subsequently, trocar 730 is
retracted sufficiently to release the self-expanding engagement
arms 106 of the mitral valve prosthesis. Typically, dilator 732 is
presented between leaflets of valve 128. Trocar 730 can be rotated
and adjusted as necessary to align the valve prosthesis so that
engagement arms 106 are positioned so as to be placed around
leaflets of native valve 128.
[0153] As shown in FIG. 7C, subsequently, trocar 730 and the valve
prosthesis are advanced forward, such that outer engagement arms
106 embrace without squeezing leaflets of native valve 128. As
shown in FIG. 7D, subsequently, dilator 732 is advanced into the
left atrium to further expose inner support structure 102, and more
specifically, to begin disengaging upstream section 116 from
dilator 732. FIG. 7E shows upstream section 116 released from
dilator 732, and expanded to press against the interior wall of
native mitral valve 128. (For some applications, upstream section
116 does not expand against the interior wall of the native valve
so as to exert a substantial radial force on the inner wall of the
valve. Rather, the upstream section is configured to prevent the
prosthesis from migrating into the left ventricle, as described
hereinabove.) Subsequently, trocar 730 is withdrawn from heart 124,
and the incision in apex 724 is closed, as shown in FIG. 7F.
[0154] It is noted that in the transition from FIG. 7C to FIG. 7E,
the width W1 that is spanned by each of the engagement arms
increases. Typically, during placement of the engagement arms on
the native valve leaflets, each of the engagement arms spans a
width that is less than 12 mm, e.g. less than 8 mm, as shown in
FIG. 7C. Typically, this prevents the engagement arms from coming
into contact with the papillary muscles, since the engagement arms
span a sufficiently narrow width so as to be placed between the
papillary muscles. Further typically, this allows the native valve
to continue functioning at least in part, since there are portions
of the leaflets that are outside the engagement arms that may
continue to open and close, at least partially. Subsequently, the
engagement arms expand (typically, due to the expansion of the
inner support structure) such that each of the engagement arms
spans a width of more than 15 mm, e.g., more than 35 mm, as shown
in FIG. 7E.
[0155] Reference is now made to FIGS. 8A-F, which are schematic
illustrations of respective steps of a transatrial implantation
procedure of mitral valve prosthesis 100 (described hereinabove
with reference to any of FIGS. 1-6), in accordance with some
applications of the present invention.
[0156] As shown in FIG. 8A, dilator 732 and trocar 730 are inserted
through an incision 840 made in the wall of the left atrium of
heart 124. Dilator 732 and trocar 730 are advanced through the
native mitral valve 128 and into the left ventricle of heart 124.
As shown in FIG. 8B, subsequently, dilator 732 is withdrawn from
trocar 732. Subsequently, a guide wire 842 is advanced through
trocar 730 to the point where mitral valve prosthesis 100 comes to
the end of trocar 730, as shown in FIG. 8C. As shown in FIG. 8D,
subsequently, mitral valve prosthesis 100 is advanced sufficiently
to release the self-expanding engagement arms 106 from trocar 730.
Trocar 730 is typically rotated and adjusted as necessary to
properly align the valve prosthesis with native valve 128.
Subsequently, trocar 730 is withdrawn slightly so as to place
engagement arms 106 around the outside of leaflets of native valve
128, as shown in FIG. 8E. Subsequently, trocar 730 is completely
withdrawn from heart 124 such that mitral valve prosthesis 100
self-expands into position and assumes the function of native
mitral valve 128, as shown in FIG. 8F.
[0157] For some applications (not shown), prosthesis 100 (described
hereinabove with reference to any of FIGS. 1-6) is implanted
transseptally. For such applications, the prosthesis is advanced
via the femoral vein, into the right atrium. An incision is made in
the septum of the heart to provide access to the left atrium. The
prosthesis is then advanced through the incision in the septum and
is implanted through a technique similar to the one described
hereinabove with reference to FIGS. 8C-8F. Such a method typically
includes some or all of the following: making an incision in a
femoral vein; inserting a trocar through the incision in the
femoral vein and advancing the trocar into the right atrium of the
heart; making an incision in the septum of the heart; advancing the
trocar through the incision in the septum of the heart and into the
left atrium; advancing a mitral valve prosthesis through the trocar
and into the left atrium of the heart; advancing the trocar past
the native mitral valve and into the left ventricle of the heart;
releasing the engagement arms from the trocar; retracting the
trocar such that the engagement arms are placed around the outer
surface of the native mitral valve leaflets; releasing the inner
support structure from the trocar; closing the incision in the
septum; and withdrawing the trocar from the heart.
[0158] Reference is now made to FIG. 9, which is a schematic
illustration of implanted mitral valve prosthesis 100 (described
hereinabove with reference to any of FIGS. 1-6), in accordance with
some applications of the present invention. Mitral valve prosthesis
100 has engagement arms 106 that are placed around leaflets of
native valve 128. Typically, downstream ends of engagement arms
define a rotational gap. When valve prosthesis 100 is implanted in
the native mitral valve, the commissures of the native mitral
valve, and the regions of the native leaflets adjacent to the
commissures are squeezed within the gap between the two ends of
outer engagement arms 106. The leaflets are squeezed within the gap
such that the regions of the anterior and posterior leaflets that
are adjacent to the commissures are squeezed against one another
and seal the commissures.
[0159] Reference is now made to FIGS. 10A-D, which are schematic
illustrations of engagement arms 106 of mitral valve prosthesis
100, in accordance with respective applications of the present
invention. In accordance with respective applications, engagement
arms 106 form a U-shaped troughs 110 (FIG. 10A), circular-shaped
troughs 111 (FIG. 10B), bulging flask-shaped troughs 113 (FIG.
10C), and/or undulating, bottle-nipple shaped trough 115 (FIG.
10D). For some applications (not shown), the engagement arms are
shaped to include two or more parallel arches.
[0160] Reference is now made to FIGS. 11A-D, which are schematic
illustrations of outer support structure 104, in accordance with
some applications of the present invention. FIG. 11A shows a single
continuous structure that includes engagement arms 106, the
engagement arms emerging from respective points of a connecting
frame 121 of the outer support structure. As shown in FIG. 11B, the
outer support structure is placed over inner support structure 102,
and is coupled to the inner support structure. For some
applications, using a single continuous structure from which the
engagement arms emerge ensures that the engagement arms are placed
symmetrically on the prosthesis, facilitates assembly of the
prosthesis, and/or enhances the overall frame strength of the
prosthesis.
[0161] As shown in FIG. 11A, for some applications, the engagements
arms include a leaflet capturing element 123 (e.g., additional
struts, as shown) to reduce motion of the native valve leaflets, to
immobilize the native valve leaflets, and/or to prevent systolic
anterior motion of the leaflets. Typically, by preventing systolic
anterior motion of the leaflets, the engagement arms prevent the
native leaflets from blocking or interfering with the LVOT. For
some applications, engagement arms 106, as described with reference
to FIGS. 11A-D, or elsewhere in the present application, prevent
systolic anterior motion of the native leaflets even in the absence
of the leaflet capturing element or any other additional
element.
[0162] As shown in FIGS. 11C-D, for some applications, the whole of
outer support structure 104 (FIG. 11C), or a portion thereof (FIG.
11D), is covered with a biocompatible cloth 145 (e.g., polyester).
Typically, the cover helps to prevent systolic anterior motion of
the native leaflets through engagement arms 106, and/or to reduce
metal to metal abrasion between the outer and inner support
structures. For some applications, the cover generally may help
capture calcific, thrombotic, or other material which might be
dislodged from the native valve or the surrounding tissue.
[0163] Reference is now made to FIG. 12, which is a schematic
illustration of the mitral valve prosthesis 100, in accordance with
some applications of the present invention. Prosthesis 100, as
shown in FIG. 12, is generally similar to prosthesis 100 described
hereinabove, except that the downstream ends of engagement arms 106
of prosthesis 100 as shown in FIG. 12 are connected directly to
inner support structure 102. As shown in FIG. 12, engagement arms
106 are attached to inner support structure 102 at downstream
section 112 of the inner support structure. In accordance with some
applications, engagement arms 106 are directly attached to inner
support structure 102 at any suitable location, including but not
limited to downstream section 112, intermediate section 116A,
and/or upstream-most section 116B (the aforementioned sections
typically being as described hereinabove with reference to FIG. 3).
For some applications, the engagement arms are integrally formed
with the inner support structure.
[0164] Reference is now made to FIG. 13, which is a schematic
illustration of mitral valve prosthesis 100, in accordance with
some applications of the present invention. Prosthesis 100, as
shown in FIG. 13, is generally similar to prosthesis 100 described
with reference to FIG. 12. However, relative to the prosthesis
shown in FIG. 12, the prosthesis shown in FIG. 13 includes a
shorter downstream section 112 of more than 1 mm and/or less than
20 mm, e.g., 1-20 mm (for example, more than 10 mm and/or less than
14 mm, e.g., 10-14 mm). In addition, relative to the prosthesis
shown in FIG. 12, engagement arms 106 of the prosthesis shown in
FIG. 13 are attached to inner support structure 102 closer to the
downstream end of the prosthesis. For some applications, use of a
shorter prosthesis improves the maneuverability of the prosthesis
when loaded on a delivery catheter, thereby facilitating
implantation of such devices and reducing the time required to
perform the implantation procedure, relative to the use of a longer
prosthesis. For some applications, use of a shorter prosthesis
reduces interference of the prosthesis with the left ventricular
outflow tract (LVOT), relative to a longer prosthesis.
[0165] Reference is now made to FIGS. 14A-B, which are schematic
illustrations of portions of mitral valve prosthesis 100, in
accordance with some applications of the present invention. FIGS.
14A-B shows a single outer support structure 104 that includes
engagement arms 106, the engagement arms emerging from respective
points of the continuous structure. Connecting frame 123 of the
outer support structure includes struts that are geometrically
similar in structure to the corresponding struts on the inner
support structure 102. For some applications, using struts that are
similar to the corresponding struts on the inner support structure
enhances the frame strength of the prosthesis, when the inner and
outer support structures are coupled to one another.
[0166] In accordance with respective applications, engagement arms
106 are coupled to connecting frame 123 of outer support structure
104, or the engagement arms and the connecting frame form a single
continuous structure. As described hereinabove with reference to
FIGS. 11A-B, for some applications, using a single continuous
structure from which the engagement arms emerge ensures that the
engagement arms are placed symmetrically on the prosthesis,
facilitates assembly of the prosthesis, and/or enhances the overall
frame strength of the prosthesis.
[0167] As shown in FIG. 14B, for some applications, at least a
portion of outer support structure 104 is covered with a
biocompatible cloth 145 (e.g., polyester). Typically, the cover
helps to prevent systolic anterior motion of the native leaflets
through engagement arms 106, and/or to reduce metal to metal
abrasion between the outer and inner support structures. For some
applications, the cover generally may help capture calcific,
thrombotic, or other material which might be dislodged from the
native valve or the surrounding tissue.
[0168] Reference is now made to FIGS. 15A-B, which are schematic
illustrations of mitral valve prosthesis 100, in accordance with
some applications of the present invention. For some applications,
during the construction of the mitral valve prosthesis, engagement
arms 106 are cut as integral parts of inner support structure 102.
Engagement arms 106 are folded into position with respect to inner
support structure 102 using heat treatment. FIG. 15B shows the
engagement arms having been folded into position, with respect to
the inner support structure.
[0169] Features of mitral valve prosthesis 100 described with
reference to respective figures are not limited to the prostheses
shown in those figures. Rather, features of the prosthesis shown in
any of the figures could be used in combination with any of the
other features described herein, mutatis mutandis. Examples of the
features that may be combined with each other include, but are not
limited to: [0170] structures of the cells of inner support
structure 102 [0171] asymmetrical engagement arms 106 of FIGS.
2A-D, [0172] the features of inner support structure 102 and outer
support structure 104 described with reference to FIGS. 4A-F [0173]
the features of inner support structure 102 described with
reference to FIGS. 5A-B [0174] the asymmetric inner support
structure, and fixation barbs of the inner support structure, as
described with reference to FIGS. 6A-D [0175] features of the outer
support structure, and/or the engagement arms described with
reference to FIGS. 9-15B.
[0176] Further, any of the surgical techniques described herein can
be used for implantation of prosthesis 100, including but not
limited to, methods of implanting the mitral valve prosthesis
transapically, transatrially, and transseptally, for example, as
described hereinabove with reference to FIGS. 7-8.
[0177] As used herein, the terms "upstream" and "downstream" are
used to refer to the upstream and downstream directions of the
blood flow when mitral valve prosthesis 100 is implanted inside the
subject's heart. The terms "upstream" and "downstream" should be
interpreted as being interchangeable, respectively, with the terms
"proximal" and "distal."
[0178] The techniques described herein may be combined with the
techniques described in one or more of the following applications,
all of which applications are incorporated herein by reference:
[0179] US 2008/0071368 to Tuval [0180] US 2009/0281618 to Hill
[0181] US 2010-0036479 to Hill
[0182] It will be appreciated by persons skilled in the art that
the present invention is not limited to what has been particularly
shown and described hereinabove. Rather, the scope of the present
invention includes both combinations and subcombinations of the
various features described hereinabove, as well as variations and
modifications thereof that are not in the prior art, which would
occur to persons skilled in the art upon reading the foregoing
description.
* * * * *